Extended Safety and Tolerability of Subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative Women: Study Protocol for the Randomised, Placebo-Controlled Double-Blinded, Phase 2 CAPRISA 012C Trial.Sharana Mahomed,Nigel Garrett, Disebo Potloane,Izukanji T. Sikazwe,Edmund Capparelli,Ishana Harkoo,Tanuja Narayansamy Gengiah,Nonhlanhla Yende Zuma,Farzana Osman,Leila Mansoor,Derseree Archary,Nqobile Myeni,Precious Radebe,Natasha Samsunder,Nicole Doria-Rose,Kevin Carlton,Lucio Gama,Richard A. Koup,Sandeep Narpala,Leonid Serebryannyy,Penny Moore,Carolyn Williamson,Bruno Pozzetto,Catherine Hankins,Lynn Morris,Quarraisha Abdool Karim,Salim Abdool KarimBMJ Open（2023）引用 0|浏览55关键词HIV & AIDS,public health,epidemiology,preventive medicine,immunologyAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
